| Revenue | DKK 2K | -50% |
| EBITDA | DKK 2K | -50% |
| Net profit | DKK 1K | -61% |
| Total assets | DKK 49K | +6% |
| Equity | DKK 44K | +3% |
| Employees | — | — |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -12 | -2 | -1 | -2 | -2 | -2 | -2 | -2 | 0 | 4 | 2 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -12 | -2 | -1 | -2 | -2 | -2 | -2 | -2 | 0 | 4 | 2 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -12 | -2 | -1 | -2 | -2 | -2 | -2 | -2 | 0 | 4 | 2 |
| Net financials | 0 | 0 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 0 |
| Profit before tax | -12 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 2 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 1 |
| Net profit | -12 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 4 | 1 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 43 | 41 | 41 | 41 | 41 | 41 | 41 | 41 | 44 | 46 | 49 |
| Equity | 38 | 36 | 36 | 36 | 36 | 36 | 36 | 36 | 39 | 42 | 44 |
| Long-term debt | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 |
| Total debt | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EW Management | Management | 2015 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ARKMEDIC ApS | Company | 25.0% | 25.0% | 2015 |
Investeringsselskabet Stjernholmsgade 7A ApS | Company | 20.0% | 20.0% | 2016 |
| Individual | 10.0% | 5.0% | 2015 | |
| Individual | 10.0% | 10.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2015 | |
| Individual | 5.0% | 5.0% | 2015 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Wihlborg | Management | 0 companies |